MADISON, Wis.--(BUSINESS WIRE)--Roche NimbleGen (SIX: RO, ROG; OTCQX: RHHBY) announced today that Seoul-based genomic services provider Macrogen, Inc. has officially joined the Roche NimbleGen Certified Service Provider (CSP) Program. Macrogen has been certified to process customer samples for NimbleGen Comparative Genomic Hybridization/Copy Number Variation (CGH/CNV) services in their lab in Seoul. As a CSP, Macrogen will process gDNA samples for CGH/CNV using the complete NimbleGen array CGH workflow which includes the high-resolution NimbleGen MS 200 Microarray Scanner. Due to the company’s previous experience using NimbleGen arrays and their certification as a service provider, Macrogen will be able to provide an extremely high level of array service to customers for high-throughput array and data processing. Macrogen had successfully finished the Korea Centers for Disease Control and Prevention (KCDC) CNV projects using Roche NimbleGen aCGH microarrays in 2009. The KCDC CNV project was two-phase study including large-scale characterization of CNVs in Korean populations and analysis of common CNVs in genome-wide association studies for 6,000 Korean individuals.
